Expectations going into 3Q23 Earnings Season

Tomorrow 3Q23 earning season begins for the US banks. Compared to last quarter analysts are more sanguine going into this quarter’s earnings season. In our universe of 285 US Banks with sell-side analyst coverage, the median revision since August 31st in next twelve months earnings (NTM) EPS estimates has been 0%. The skew is to the downside, however. Of the 46.7% in the universe with a downward revision, the average revision was -2.8% while those receiving an upward revision the average was just 1.6%. Compare this with the equivalent pre-earnings season revision in 2Q23 (i.e. May 31 to 2Q23 earnings release). The median revision was -3.0% with 79.0% in the universe receiving a downward revision which averaged -5.9% while those receiving an upward revision the average was just 1.0%.

Chart 1

Chart 2

Despite this relative optimism from analysts, we at Cybiont Capital remain bearish anticipating further downward revisions to analysts’ NTM EPS estimates post 3Q23 results on our expectation of three broad themes emerging from results.

  • Continued NIM compression albeit at a slower pace than 2Q23’s rate reflecting decelerating funding cost increases and accelerating loan yield expansions.
  • Anticipated announcements from Bank management over restructurings on underwater securities books
  • Incipient deterioration in credit quality expressed as rising non-performing loan formation rates most prominently in non-prime unsecured and auto loans as well as non-owner occupied CRE.

Author

  • Entrepreneur, & Advisor with more than 30 years of proven innovative analytical skills delivering market-leading investment advice on Financial Institutions to many of the world’s leading global asset management firms. Success in Europe, Latin America, the U.S., and Canada, having held senior leadership roles on the buy-and sell- side as well as in financial institutions.

    View all posts


One response to “Expectations going into 3Q23 Earnings Season”

  1. […] reported so far), the pace of Net Interest Margin (NIM) contraction appears to be slowing as we had anticipated. Chart 1 displays the path of NIMs over the last four quarters on a consistent cohort basis of the […]

Leave a Reply

About Us

We are your banking experts.

Private Equity: We are a trusted partner for family offices and other investors seeking to invest in U.S. banks in the private markets. We source investment opportunities and provide diligence services and ongoing monitoring of bank investments for family offices and other investors for whom we provide cost-effective confidence for their financial company investments.

Public Markets: We structure bank investment portfolios providing risk-tailored strategies by systematically integrating fundamental and technical analysis building alpha-generating long/short portfolios from the nearly 300 liquid publicly traded banking companies in the U.S. markets. If you want bank equity exposure with tailored risk parameter’s, we’re your source.

Cybiont is…

Our Investment Philosophy

Recieve Cybiont’s analysis in your email as it’s released:

Discover more from Cybiont Capital, LLC

Subscribe now to keep reading and get access to the full archive.

Continue reading

Discover more from Cybiont Capital, LLC

Subscribe now to keep reading and get access to the full archive.

Continue reading